Notice of Correction to Application Types Allowed for RFA-MH-17-602 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33)"

Notice Number: NOT-MH-17-020

Key Dates
Release Date: April 5, 2017

Related Announcements
RFA-MH-17-602

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to correct the Applications Types Allowed in RFA-MH-17-602.

Part 2.  Full Text of Announcement
Section II. Award Information

Current language:


Application Types Allowed

New
Resubmission from RFA-MH-15-300, RFA-MH-16-400 or RFA-MH-17-602
Revision from RFA-MH-15-300, RFA-MH-16-400 or RFA-MH-17-602

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Revised Language:


Application Types Allowed

New
Resubmission from RFA-MH-15-310, RFA-MH-16-400 or RFA-MH-17-602
Revision from RFA-MH-15-310, RFA-MH-16-400 or RFA-MH-17-602

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:


For Pediatric Studies
Margaret Grabb, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3563
Email: mgrabb@mail.nih.gov

For Adult Studies
Mi Hillefors, M.D., Ph.D.
National Institute of Mental Health (NIMH)
Telephone:  301-443-2738
Email:  mi.hillefors@nih.gov

For Geriatric Studies
Jovier Evans, Ph.D.
National Institute of Mental Health (NIMH)
Telephone:  301-443-6328
Email:  jevans1@mail.nih.gov